Skip to content
healthcare.dev

Naproxen

NDC 50228-435, Naproxen, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-435
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212517
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-435 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN375 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
50228-435-0150228043501100 TABLET in 1 BOTTLE (50228-435-01)
50228-435-0550228043505500 TABLET in 1 BOTTLE (50228-435-05)
50228-435-10502280435101000 TABLET in 1 BOTTLE (50228-435-10)
50228-435-305022804353030 TABLET in 1 BOTTLE (50228-435-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/81e22c1f-f94d-46e9-8b7d-72dc2518319e
  • NADAC price for package 50228043501

    GET /v1/drugs/nadac/50228043501
  • NADAC price for package 50228043505

    GET /v1/drugs/nadac/50228043505

Use it

Look up 50228-435 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-435 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-435. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.